Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 24,650 |
|
|||||
| News | - | ||||||
| Day High | 3.03 | Low High |
|||||
| Day Low | 2.98 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Relmada Therapeutics Inc | RLMD | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0001 | 0.00% | 3.0099 | 10:15:45 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 3.01 | 2.98 | 3.03 | 3.01 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 194 | 24,650 | US$ 3.01 | US$ 74,234 | - | 2.3601 - 7.2225 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 10:15:45 | 1 | US$ 2.99 | USD |
Relmada Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 90.3M | 30.10M | - | 0 | -98.79M | -3.28 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Relmada Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RLMD Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.93 | 3.24 | 2.9226 | 3.06 | 60,436 | 0.0799 | 2.73% |
| 1 Month | 3.36 | 3.44 | 2.45 | 3.04 | 106,118 | -0.3501 | -10.42% |
| 3 Months | 4.80 | 5.13 | 2.45 | 3.85 | 107,872 | -1.79 | -37.29% |
| 6 Months | 2.46 | 7.2225 | 2.43 | 4.17 | 226,497 | 0.5499 | 22.35% |
| 1 Year | 2.60 | 7.2225 | 2.3601 | 3.61 | 196,760 | 0.4099 | 15.77% |
| 3 Years | 32.03 | 38.68 | 1.81 | 11.66 | 325,840 | -29.02 | -90.60% |
| 5 Years | 10.85 | 54.00 | 1.81 | 16.57 | 253,804 | -7.84 | -72.26% |
Relmada Therapeutics Description
| Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications. |
